romiplostim在接受免疫抑制治疗naïve的获得性再生障碍性贫血儿童中的安全性和有效性。

IF 7.9 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-07-24 DOI:10.3324/haematol.2025.288078

Mohammadreza Bordbar,Alireza Faghihi,Omid Reza Zekavat,Mahdi Shahriari,Shayan Bordbar

引用次数: 0

摘要

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Safety and efficacy of romiplostim in children with acquired aplastic anemia who are naïve to immunosuppressive therapy.

Not available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.